GENYCA launches a new genetic study of Diabesidad: analysis of DNA against obesity and diabetes
GENYCA analyzes DNA to preserve health and improve the quality of life with personalized treatments.
-GENYCA first laboratory in Spain who put the scope of all the genetic test of 18 obesity genes, now launches a new study Diabesidad.
-analysis of 7 Diabesidad genes in obese patients lets you really customize treatment, because there is nothing more personal than the genetic information of each.
– these genetic studies are carried out from a sample of saliva, either in the laboratory or at home (by sending the sampling kit anywhere in the world) and are valid for life.
Madrid, may 2012.- The company GENYCA, specialized in analysis and genetic diagnosis has launched a new genetic study of Diabesidad, to evaluate the risk cardiometabólico in the patient, especially if it presents fat located abdominal level.
With this system you can study the origins of the overweight of any individual and their associated metabolic implications, to treat a personalized way and much more effective than other tests, the genetic analysis is only for life.
Obesity occurs due to an imbalance between the contribution and the energy expenditure, and the factors influencing this imbalance are two: genetic and environmental. The recent and accelerated development of the Molecular Genetics has been a big push in the understanding of the mechanisms involved in the genetics of obesity. The analysis of certain regions of the DNA or genes in obese patients, provides specialist very valuable information when it comes to personalizing each patient’s treatment and thereby change the second factor in obesity, the habits of behavior and food (environmental factors).
These genetic studies of diabesidad are made from a sample of saliva, painless and simple method. The sample is taken by rubbing a bud against the walls of the interior of the mouth, and is either in the laboratory or by mail anywhere in Spain.
GENYCA doctor also offers personalized and unique for each patient, treatment based on information of the genome, indicating how should eat, what physical exercise allows you to burn more calories in your case, how to avoid the appearance of disorders cardiovascular if you have predisposition, etc. The follow-up of the patient remain important to achieve a more effective treatment.
For Teresa Perucho, General Director of INNOVA GENYCA there is nothing more personal than the genetic information of a person. Now it can be used to preserve the health and improve the quality of life ”. Obesity is closely related to insulin resistance and cardiovascular problems, which means that people who are obese have a greater predisposition to suffer from type 2 Diabetes Mellitus and cardiovascular accident. All this can be avoided by doing a proper Predictive Medicine.
Kit (sterile swabs for sample of saliva and your shipment by courier) + 7 genes analysis + consultation cost 260 €.
To know más:
The GENYCA INNOVA analysis and diagnostic genetic S.L. company began its activity in 2005, after having achieved the first health authorisation as genetics unit granted by the community of Madrid to a private lab. It has the quality certification ISO 9001: 2008, and works under the guidelines established by the ISO/IEC 17025 and ISO 15189 standards.
The main activity of this laboratory specializing in molecular genetic analyses, focuses on different areas:
to) genetic diagnosis: hereditary, infectious diseases, etc.
(b) Predictive Medicine: genetic risk to cancer, Alzheimer’s disease, osteoporosis, etc. Featured services: genetic of the celiac disease and obesity. (
c) Genetic counselling: in the premises of Genyca or concerted clinics. (
d) Genetic identification: identification remains in mass graves, evidence of paternity …
e) support for basic research of hospitals or universities. (
f) Specialized training: classroom Genyca regularly organizes specialized courses in the field of genetics, as genetic counselling psychology, techniques of Molecular Biology, bioinformatics, etc.
